Journal of Internal Medicine Concepts & Practice ›› 2021, Vol. 16 ›› Issue (01): 1-3.doi: 10.16138/j.1673-6087.2021.01.001
• Editorial • Next Articles
Received:
2021-02-10
Online:
2021-02-25
Published:
2021-05-27
CLC Number:
[1] |
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2020, 395(10225): 709-733.
doi: 10.1016/S0140-6736(20)30045-3 URL |
[2] |
Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review[J]. Lancet, 2015, 385(9981): 1975-1982.
doi: 10.1016/S0140-6736(14)61601-9 URL |
[3] | Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update[J]. Am J Kidney Dis, 2020, 75(4 Suppl 2): S1-S164. |
[4] |
Yu Y, Xiong Y, Zhang C, et al. Vascular access type was not associated with mortality and the predictors for cardiovascular death in elderly Chinese patients on hemodialysis[J]. Blood Purif, 2020, 49(1-2): 63-70.
doi: 10.1159/000502941 URL |
[5] |
Lookstein RA, Haruguchi H, Ouriel K, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas[J]. N Engl J Med, 2020, 383(8): 733-742.
doi: 10.1056/NEJMoa1914617 URL |
[6] |
Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China[J]. J Am Soc Nephrol, 2020, 31(7): 1387-1397.
doi: 10.1681/ASN.2020030354 pmid: 32385130 |
[7] |
Ajaimy M, Melamed ML. COVID-19 in patients with kidney disease[J]. Clin J Am Soc Nephrol, 2020, 15(8): 1087-1089.
doi: 10.2215/CJN.09730620 URL |
[8] |
Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2[J]?. Am J Physiol Renal Physiol, 2020, 318(6): F1454-F1462.
doi: 10.1152/ajprenal.00160.2020 URL |
[9] |
Roberts MA, Polkinghorne KR, McDonald SP, et al. Se-cular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population[J]. Am J Kidney Dis, 2011, 58(1): 64-72.
doi: 10.1053/j.ajkd.2011.01.024 URL |
[10] |
Smyth B, Haber A, Trongtrakul K, et al. Representativeness of randomized clinical trial cohorts in end-stage kidney disease: a meta-analysis[J]. JAMA Intern Med, 2019, 179(10): 1316-1324.
doi: 10.1001/jamainternmed.2019.1501 URL |
[11] |
Ajmal F, Probst JC, Brooks JM, et al. Freestanding dialysis facility quality incentive program scores and mortality among incident dialysis patients in the United States[J]. Am J Kidney Dis, 2020, 75(2): 177-186.
doi: 10.1053/j.ajkd.2019.07.023 URL |
[12] | 洪大情, 何强, 蒲蕾, 等. 2011年度四川省血液透析患者死亡情况分析[J]. 中国血液净化, 2012, 11(10): 575-578. |
[13] |
Hong D, Wu S, Pu L, et al. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study[J]. BMC Nephrol, 2013, 14: 120.
doi: 10.1186/1471-2369-14-120 URL |
[14] |
Ketteler M, Block GA, Evenepoel P, et al. Diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder: synopsis of the kidney disease: improving global outcomes 2017 clinical practice guideline update[J]. Ann Intern Med, 2018, 168(6): 422-430.
doi: 10.7326/M17-2640 pmid: 29459980 |
[15] | 国家肾脏疾病临床医学研究中心. 中国慢性肾脏病矿物质和骨异常诊治指南概要[J]. 肾脏病与透析肾移植杂志, 2019, 28(1): 52-57. |
[16] | Li Y, Shi H, Wang WM, et al. Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study[J]. Medicine(Baltimore), 2016, 95(24): e3872. |
[17] |
Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease[J]. Am J Kidney Dis, 1996, 28(1): 53-61.
pmid: 8712222 |
[18] |
Zuo L, Wang M, Hou F, et al. Anemia management in the China dialysis outcomes and practice patterns study[J]. Blood Purif, 2016, 42(1): 33-43.
doi: 10.1159/000442741 URL |
[19] |
Chen N, Hao C, Liu BC, et al. Roxadustat treatment for anemia in patients undergoing long-term dialysis[J]. N Engl J Med, 2019, 381(11): 1011-1022.
doi: 10.1056/NEJMoa1901713 URL |
[20] | 林珍, 王池凤, 邓琼丽, 等. 信息化管理在我院血透护理中的应用[J]. 名医, 2020, (1): 294. |
[21] | 张宇, 米春香. 基于BS架构的血液透析患者排床管理系统开发[J]. 医学信息, 2020, 33(4): 20-22. |
[22] | 李占霞, 黄嘉琳, 倪洁, 等. 电子信息化管理系统对血液透析室护理人员心理资本、工作投入状况的影响[J]. 实用临床医药杂志, 2020, 24(8): 26-28. |
[23] | 张金霞, 丁晓仙, 陈益. 信息化管理系统在血透室专科指标监测管理中的应用体会[J]. 基层医学论坛, 2020, 24(3): 442-443. |
[24] | 施建文, 曹亮, 施春艳. 血液透析信息化系统方案设计与实践[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(73): 231-232. |
[25] | Burlacu A, Iftene A, Jugrin D, et al. Using artificial intelligence resources in dialysis and kidney transplant patients: a literature review[J]. Biomed Res Int, 2020, 2020: 9867872. |
[26] | Xie G, Chen T, Li Y, et al. Artificial intelligence in nephrology: how can artificial intelligence augment nephrologists' intelligence[J]?. Kidney Dis (Basel), 2020, 6(1): 1-6. |
[1] | ZHANG Xiaoyan, XU Jing, QU Bin. Effect of serum vitamin D level on renal function in elderly patients with chronic kidney disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 307-312. |
[2] | ZHANG Chunli, XU Jing, PAN Xiaoxia, HU Xiaofan, LI Ya. Analysis of clinical and histological features of IgG4-related kidney disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(03): 214-219. |
[3] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(05): 366-370. |
[4] | XUAN Yingli, CHEN Feihong, QIN Li, HE Ruibin, PANG Shiqing, YUAN Jiangzi. Correlation analysis of vitamin D and nocturnal blood pressure in the patients with chronic kidney disease [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 246-250. |
[5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 49-52. |
[6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 4-9. |
[7] | WANG Xuejie, CHEN Zijin, DU Wen, GU Feifei, YU Haijin, ZHANG Wen, CHEN Xiaonong. Risk factors of acute kidney injury in the patients with bloodstream infection caused by different pathogens [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 22-26. |
[8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 15-17. |
[9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 10-14. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||